ArisGlobal Differentiates Automation Hype from Reality in Pharmacovigilance for the Life Sciences Industry
During our recent webinar, when polled 43% of the audience said automating PV processes was one of their top strategic priorities, while 13% have no automation plan in place. That and other interesting insights are shared in this first of a three-part blog series.